Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
24 pending office actions • 21 art units • 22 examiners • 0 of 24 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Beth Israel Deaconess Medical Center Inc. manages 24 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 24 actions are spread across 21 distinct art units, indicating a broad and diverse research portfolio. The company interacts with 22 distinct examiners to move these cases forward. This high number of 21 art units for only 24 actions suggests that almost every pending matter represents a different technical sub-specialty. Practitioners must use a highly tailored prosecution approach for each of the 22 examiners.
GEIGER, RACHAEL L is the busiest examiner, with 2 pending office actions. The other actions are distributed among the remaining distinct examiners. This distribution means that many of the 24 pending office actions are handled by unique individuals. With 24 actions across 21 art units, the company faces a decentralized prosecution process. The 22 distinct examiners provide a range of feedback on the company's biotechnological and pharmaceutical innovations. This portfolio requires managing many separate examiner relationships simultaneously.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (4%) |
| §101 + other | 4 (17%) |
| §103 only | 7 (29%) |
| §112 only | 1 (4%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 9 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GEIGER, RACHAEL L | 2 | 82.3% | +18.3% |
| TRAN, LARA LINH | 2 | 16.7% | +90.9% |
| BALAJ, ANTHONY MICHAEL | 1 | 30.6% | +30.6% |
| PYLA, EVELYN Y | 1 | 55.7% | +47.1% |
| SUN, CAITLYN MINGYUN | 1 | 63.5% | +11.9% |
| WORSHAM, JESSICA N | 1 | 56.3% | +56.3% |
| WU, PAMELA F | 1 | 57.3% | +22.2% |
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
| HAWTHORNE, OPHELIA ALTHEA | 1 | 72.0% | +30.2% |
| IVANOVA, SVETLANA M | 1 | 50.9% | +51.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274028 | ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION | SUN, CAITLYN MINGYUN | 30d overdue |
| 17133277 | LYMPHATIC ANASTOMOSIS DEVICES AND METHODS | GEIGER, RACHAEL L | 29d |
| 19314645 | SYSTEM AND METHOD FOR ALGORITHMIC DIAGNOSTICS FOR EFFICIENT PRESCRIPTION OF TREATMENTS FOR B-SNIP PSYCHOSIS BIOTYPES | BALAJ, ANTHONY MICHAEL | — |
| 15844440 | LASER SURGICAL INSTRUMENT FOR SPINAL ENDOSCOPIC DECOMPRESSION | WU, PAMELA F | — |
| 18726658 | THERMALLY ACTIVATED PESSARY | HAWTHORNE, OPHELIA ALTHEA | — |
| 18752514 | LYMPHATIC ANASTOMOSIS DEVICES AND METHODS | GEIGER, RACHAEL L | — |
| 18700227 | METHODS FOR TREATING A TRAUMA PATIENT | IVANOVA, SVETLANA M | — |
| 18550008 | Methods of Identifying Active Lupus Nephritis Flare | SITTON, JEHANNE SOUAYA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17926040 | METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE | WORSHAM, JESSICA N | 44d overdue |
| 18274028 | ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION | SUN, CAITLYN MINGYUN | 30d overdue |
| 18934169 | COMPOUNDS AND METHODS FOR USING GALLOYLATED POLYPHENOLS TO TREAT DISEASES MEDIATED BY THIOL ISOMERASES | GONZALEZ, LUISALBERTO | 27d |
| 17133277 | LYMPHATIC ANASTOMOSIS DEVICES AND METHODS | GEIGER, RACHAEL L | 29d |
| 19314645 | SYSTEM AND METHOD FOR ALGORITHMIC DIAGNOSTICS FOR EFFICIENT PRESCRIPTION OF TREATMENTS FOR B-SNIP PSYCHOSIS BIOTYPES | BALAJ, ANTHONY MICHAEL | — |
| 18771037 | SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING | PYLA, EVELYN Y | — |
| 15844440 | LASER SURGICAL INSTRUMENT FOR SPINAL ENDOSCOPIC DECOMPRESSION | WU, PAMELA F | — |
| 18726658 | THERMALLY ACTIVATED PESSARY | HAWTHORNE, OPHELIA ALTHEA | — |
| Art Unit | Apps |
|---|---|
| 3771 | 2 |
| 3682 | 1 |
| 1795 | 1 |
| 1615 | 1 |
| 3795 | 1 |
| 1624 | 1 |
| 3786 | 1 |
| 1627 | 1 |
| 2674 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19314645 | SYSTEM AND METHOD FOR ALGORITHMIC DIAGNOSTICS FOR EFFICIENT PRESCRIPTION OF TREATMENTS FOR B-SNIP PSYCHOSIS BIOTYPES | BALAJ, ANTHONY MICHAEL | 3682 | §101§103 | Non-Final OA | — | Pending | Aug 29, 2025 |
| 18771037 | SYSTEM AND METHOD FOR CELL LEVITATION AND MONITORING | PYLA, EVELYN Y | — | DP | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18274028 | ELECTROPHORETIC MOBILITY SHIFT AS A MOLECULAR BEACON-BASED READOUT FOR MIRNA DETECTION | SUN, CAITLYN MINGYUN | 1795 | §103§112 | Non-Final OA | 30d overdue | Pending | Jul 25, 2023 |
| 17926040 | METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE | WORSHAM, JESSICA N | 1615 | §103 | Non-Final OA | 44d overdue | Pending | Nov 17, 2022 |
| 15844440 | LASER SURGICAL INSTRUMENT FOR SPINAL ENDOSCOPIC DECOMPRESSION | WU, PAMELA F | 3795 | §103§112 | Non-Final OA | — | Pending | Dec 15, 2017 |
| 18934169 | COMPOUNDS AND METHODS FOR USING GALLOYLATED POLYPHENOLS TO TREAT DISEASES MEDIATED BY THIOL ISOMERASES | GONZALEZ, LUISALBERTO | 1624 | §112 | Non-Final OA | 27d | Pending | Oct 31, 2024 |
| 18726658 | THERMALLY ACTIVATED PESSARY | HAWTHORNE, OPHELIA ALTHEA | 3786 | §102§103 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18752514 | LYMPHATIC ANASTOMOSIS DEVICES AND METHODS | GEIGER, RACHAEL L | 3771 | §101§102§103 | Non-Final OA | — | Pending | Jun 24, 2024 |
| 18700227 | METHODS FOR TREATING A TRAUMA PATIENT | IVANOVA, SVETLANA M | 1627 | §103§112 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18409385 | SYSTEM AND METHOD FOR IMAGE TEMPORAL INTERPOLATION FOR DYNAMIC IMAGING | BLACKSTEN, SYDNEY LYNN | 2674 | §103 | Final Rejection | 13d | Pending | Jan 10, 2024 |
| 18489525 | METHODS FOR PREVENTING AND TREATING HEART DISEASE | LANDSMAN, ROBERT S | 1647 | §112DP | Final Rejection | 56d | Pending | Oct 18, 2023 |
| 18550008 | Methods of Identifying Active Lupus Nephritis Flare | SITTON, JEHANNE SOUAYA | 1682 | §101§102§103 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18254045 | DEVICE AND METHOD FOR FENESTRATION ALIGNMENT | TRAN, LARA LINH | — | §102§103§112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18036455 | SYSTEMS AND METHODS FOR IMPROVING SLEEP AND OTHER INDICATIONS, INCLUDING TREATING ANXIETY | YANG, YI-SHAN | 3798 | §103 | Non-Final OA | 23d overdue | Pending | May 11, 2023 |
| 18133962 | MICROSPHERE DELIVERY APPARATUS PROVIDING REAL-TIME MEASURING OF DELIVERED RADIOACTIVITY | TRAN, LARA LINH | 3791 | §103§112 | Non-Final OA | — | Pending | Apr 12, 2023 |
| 18041271 | ANTI-SEED PNAS AND MICRORNA INHIBITION | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Feb 10, 2023 |
| 18096246 | EXTERNAL FIXATION CLAMP AND SYSTEMS FOR MEDICAL PROCEDURES | JANSSEN, REBECCA | 1733 | §103§112 | Non-Final OA | — | Pending | Jan 12, 2023 |
| 17783180 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND MODULATING THROMBOTIC CONDITIONS IN A CANCER PATIENT | TRAN, CHAU NGUYEN BICH | 1677 | §103 | Final Rejection | — | Pending | Jun 07, 2022 |
| 17774338 | DIAGNOSIS AND TREATMENT OF NAFLD AND LIVER FIBROSIS | WALLENHORST, MAUREEN | 1797 | §101§112 | Non-Final OA | — | Pending | May 04, 2022 |
| 17765620 | DIAGNOSIS AND TREATMENT OF THYROID CANCER | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Non-Final OA | — | Pending | Mar 31, 2022 |
| 17291723 | METHODS TO PREDICT LIVER DISEASE MORTALITY USING LIPOPROTEIN LP-Z | PULLIAM, JOSEPH CONSTANTINE | 1687 | §101 | Non-Final OA | — | Pending | May 06, 2021 |
| 17250791 | METHODS OF CULTURING PODOCYTES AND COMPOSITIONS THEREOF | TRAN, KHOA NHAT | 1632 | §103§112 | Final Rejection | — | Pending | Mar 04, 2021 |
| 17133277 | LYMPHATIC ANASTOMOSIS DEVICES AND METHODS | GEIGER, RACHAEL L | 3771 | §102§103 | Non-Final OA | 29d | Pending | Dec 23, 2020 |
| 16324945 | A20 THERAPY TO ACHIEVE GLYCEMIC CONTROL | SHIN, DANA H | 1635 | §103 | Final Rejection | 15d | Pending | Feb 12, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial